Publicaciones en las que colabora con Fernando de Álvaro Moreno (21)

2021

  1. Optimizing the timing of nephrology referral for patients with diabetic kidney disease

    Clinical Kidney Journal, Vol. 14, Núm. 1, pp. 5-8

2020

  1. Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease

    Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024

2019

  1. Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort

    Frontiers in Genetics, Vol. 10, Núm. FEB

2017

  1. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520

2015

  1. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185

  2. The concept and the epidemiology of diabetic nephropathy have changed in recent years

    Journal of Clinical Medicine, Vol. 4, Núm. 6, pp. 1207-1216

2013

  1. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

    New England Journal of Medicine, Vol. 369, Núm. 26, pp. 2492-2503

  2. The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease

    BMC Nephrology, Vol. 14, Núm. 1

2012

  1. A propósito de las discrepancias entre documentos de consenso, guías de práctica clínica y normativa legal en el tratamiento de la diabetes tipo 2

    Nefrologia

  2. About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes

    Nefrologia

  3. Discrepancies between the summary of characteristics and the recommended use of metformin in the treatment of type 2 diabetes mellitus patients

    Nefrologia

2011

  1. Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: The MERENA observational cohort study

    BMC Nephrology, Vol. 12, Núm. 1

2010

  1. 10 razones para el tratamiento con olmesartán/amlodipino en el paciente hipertenso no controlado en nefrología

    International Marketing & Communication

2009

  1. Anemia development and cardiovascular risk management in nonanemic stage 3 chronic kidney disease

    Renal Failure, Vol. 31, Núm. 10, pp. 869-875

2007

  1. Glomerulopatías secundarias y enfermedades renales asociadas a enfermedades metabólicas. Diabetes mellitus.

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 80, pp. 5157-5163

2005

  1. Directrices y guías de consenso para el manejo de la nefropatía diabética: ¿Son realmente válidas?

    Nefrologia, Vol. 25, Núm. SUPPL.4, pp. 28-33

  2. Epidemiology of diabetic nephropathy in Spain

    Kidney International

  3. Trascendencia de la determinación precoz de microalbuminuria en el riesgo vascular global y nefropatía diabética

    Nefrologia, Vol. 25, Núm. SUPPL.4, pp. 34-41

2004

  1. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study)

    Journal of Nephrology, Vol. 17, Núm. 4, pp. 544-551

  2. Perceived mental health at the start of dialysis as a predictor of morbidity and mortality in patients with end-stage renal disease (CALVIDIA study)

    Nephrology Dialysis Transplantation, Vol. 19, Núm. 9, pp. 2347-2353